Literature DB >> 918357

Bronchial reactivity to prostaglandins F2alpha, E2, and histamine in different types of asthma.

A Szczeklik, E Nizankowska, R Nizankowski.   

Abstract

Bronchial reactivity to prostaglandins F2alpha (PGF2alpha), E2 (PGE2) and histamine has been studied in 27 patients with aspirin-sensitive asthma and in 28 asthmatics without this sensitivity. Of the latter group, 13 patients had atopic, 9 infectious, and 6 mixed type of asthma. Atopic patients were characterized by vivid reactivity to low doses of both PGF2alpha and histamine. In patients with infectious asthma significantly higher doses of both PGF2alpha and histamine were necessary to induce bronchoconstriction as compared to atopics. Aspirin-sensitive patients responded quickly with bronchial spasm to similar doses of histamine as atopics, but tolerated significantly higher doses of PGF2alpha. There was no difference in reactivity to PGF2alpha between patients with aspirin sensitivity and those with infectious asthma. 5 and 10 min after administration of 60 microgram PGE2 significantly better improvement in ventilation occurred in aspirin-sensitive patients than in those of either atopic or infectious groups. The results obtained point to differences in bronchial reactivity to prostaglandins and histamine depending on type of asthma and severity of its symptoms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 918357     DOI: 10.1159/000193844

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  3 in total

1.  Analgesic induced asthma.

Authors:  S Smith; J Murphy; P Cosgrove; J S Doyle
Journal:  Ir J Med Sci       Date:  1983-11       Impact factor: 1.568

2.  Bronchial hyperreactivity to histamine in aspirin sensitive asthmatics: relationship to aspirin threshold and effect of aspirin desensitisation.

Authors:  M L Kowalski; I Grzelewska-Rzymowska; M Szmidt; J Rozniecki
Journal:  Thorax       Date:  1985-08       Impact factor: 9.139

Review 3.  Analgesics, allergy and asthma.

Authors:  A Szczeklik
Journal:  Drugs       Date:  1986       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.